AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $10,025,000 | -8.4% | 130,000 | 0.0% | 2.55% | -10.0% |
Q2 2018 | $10,949,000 | +3.0% | 130,000 | 0.0% | 2.83% | -6.8% |
Q1 2018 | $10,631,000 | +43.0% | 130,000 | 0.0% | 3.04% | +27.7% |
Q4 2017 | $7,432,000 | -14.3% | 130,000 | 0.0% | 2.38% | -22.5% |
Q3 2017 | $8,677,000 | +29.7% | 130,000 | 0.0% | 3.07% | +9.8% |
Q2 2017 | $6,688,000 | -11.9% | 130,000 | 0.0% | 2.79% | -26.0% |
Q1 2017 | $7,592,000 | +39.9% | 130,000 | 0.0% | 3.78% | +18.2% |
Q4 2016 | $5,425,000 | -21.0% | 130,000 | 0.0% | 3.20% | -11.1% |
Q3 2016 | $6,867,000 | +92.8% | 130,000 | +52.9% | 3.59% | +51.1% |
Q2 2016 | $3,561,000 | -16.5% | 85,000 | -19.0% | 2.38% | -10.5% |
Q1 2016 | $4,263,000 | -49.8% | 105,000 | +16.7% | 2.66% | -32.5% |
Q1 2015 | $8,487,000 | -33.3% | 90,000 | -20.7% | 3.94% | -38.7% |
Q4 2014 | $12,717,000 | -99.8% | 113,500 | 0.0% | 6.43% | +18.4% |
Q3 2014 | $6,963,225,000 | +132054.6% | 113,500 | -1.3% | 5.43% | +19.5% |
Q2 2014 | $5,269,000 | – | 115,000 | – | 4.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 354,650 | $18,314,000 | 7.19% |
Casdin Capital, LLC | 2,165,000 | $111,801,000 | 3.33% |
Rock Springs Capital Management LP | 2,543,600 | $131,352,000 | 2.87% |
HealthCor Management, L.P. | 1,532,960 | $79,162,000 | 2.80% |
Bellevue Group AG | 4,537,092 | $234,295,000 | 2.48% |
Woodline Partners LP | 824,097 | $42,556,000 | 0.94% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,081,347 | $55,841,000 | 0.83% |
Integral Health Asset Management, LLC | 43,000 | $2,221,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,119,566 | $57,814,000 | 0.43% |
Virtus ETF Advisers LLC | 18,328 | $946,000 | 0.40% |